Volume 44, Issue 6, Pages (June 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Heat Shock Protein Expression in Rat Skeletal Muscle After Repeated Applications of Pulsed and Continuous Ultrasound  Ethne L. Nussbaum, PhD, PT, Marius.
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Volume 61, Issue 6, Pages (December 2014)
Volume 51, Issue 6, Pages (December 2009)
Volume 54, Issue 1, Pages (July 2008)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Treatment of Hyperammonemia in Liver Failure: A Tale of Two Enzymes
Immigration and viral hepatitis
Volume 138, Issue 4, Pages (April 2010)
Volume 41, Issue 3, Pages (September 2004)
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
The place of downstaging for hepatocellular carcinoma
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations  LAURA D ERRANTE, OGNEN A.C PETROFF 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Exercise in cirrhosis: Translating evidence and experience to practice
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 62, Issue 3, Pages (March 2015)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 65, Issue 2, Pages (August 2016)
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Volume 42, Issue 6, Pages (June 2005)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
HCV targeting of patients with cirrhosis
Metabolic profiling of livers and blood from obese Zucker rats
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Volume 66, Issue 4, Pages (April 2017)
Volume 66, Issue 5, Pages (May 2017)
Liver transplantation in children
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
A 360-degree overview of paediatric NAFLD: Recent insights
Volume 54, Issue 6, Pages (June 2011)
The relationship between age and fat infiltration in liver and muscle
Volume 117, Issue 3, Pages (September 1999)
Genetics of hepatocellular carcinoma: The next generation
Volume 125, Issue 3, Pages (September 2003)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

Volume 44, Issue 6, Pages 1083-1088 (June 2006) Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure  Nicolas Chatauret, Paul Desjardins, Claudia Zwingmann, Christopher Rose, K.V. Rama Rao, Roger F. Butterworth  Journal of Hepatology  Volume 44, Issue 6, Pages 1083-1088 (June 2006) DOI: 10.1016/j.jhep.2005.11.048 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 GS protein and enzyme activities in brain (cerebral cortex) and skeletal muscle of rats with ALF. (A) Representative Western blots of GS (45kDa) from two ALF rats compared to sham-operated controls. (B) GS protein data from n=8 animals per treatment group. (C) GS enzyme activities determined in cerebral cortex and skeletal muscle of eight ALF rats compared to eight sham-operated controls. Values represent mean±SE, * indicates values significantly different from sham-operated control values (P<0.05). Journal of Hepatology 2006 44, 1083-1088DOI: (10.1016/j.jhep.2005.11.048) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Muscle glutamine concentrations and de novo glutamine synthesis from [U–13C]-glucose in rats with ALF compared to sham-operated controls measured by 1H/13C NMR. (A) Representative 13C-spectra of muscle extracts, Gln C3, glutamine labeled in position C3; Glu C3, glutamate labeled in position C3. The singlet in the C3 glutamine peak position represents the natural abundance of 13C in unlabeled glutamine and monolabeled glutamine. The doublet (dashed lines) represents double-labeled [2,3-13C]-glutamine synthesized de novo from [U–13C]-glucose in the TCA cycle. (B) Muscle glutamine concentration and its de novo synthesis (13C enrichment in C3 glutamine) from glucose in ALF rat muscle compared to sham-operated controls. Values represent mean±SE from six rats per treatment group. * Indicates values significantly different from sham-operated control P<0.0001. Journal of Hepatology 2006 44, 1083-1088DOI: (10.1016/j.jhep.2005.11.048) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Schematic representation of the glutamine synthesis reaction in muscle and brain. Journal of Hepatology 2006 44, 1083-1088DOI: (10.1016/j.jhep.2005.11.048) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions